Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

231A32F7880C9D298725847F005D2929 Hearing Summary




PUBLIC
BILL SUMMARY For PUBLIC COMMENT: HARM REDUCTION BILL DRAFT

INTERIM COMMITTEE  OPIOID AND OTHER SUBSTANCE USE DISORDERS
Date Sep 24, 2019      
Location Old State Library



Public Comment: Harm Reduction Bill Draft - Committee Discussion Only


10:57:37 AM  

Dr. Stader, representing the Colorado Medical Society, spoke in support of hospital reimbursement for opioid antagonist or naloxone kits. Dr. Stader suggested adding language about discrimination for those who fill an opioid prescription. Katie Wolf, representing Colorado Pharmacist Society, suggested using the language of 'non-prescription' syringes in the bill and to add good samaritan language for pharmacists. Rica Rodriguez, representing herself, discussed adding funding for syringe access programs.

11:03:37 AM  

Senator Moreno asked about the cost of syringes . Ms. Woldf said she would follow up with the committee. Senator Moreno also asked about the efficacy of expired naloxone kits. Dr. Stader provided rational for why it would maintain efficacy. Dr. Rob Valuck, Colorado Consortium for Prescription Drug Abuse Prevention (Colorado Consortium), cited a growing body of evidence about the remaining efficacy of naloxone in expired kits.

11:07:23 AM  

Steve Silvern, representing himself, shared the story of Martin Schneider and the need for balance with prescribing opioids to ensure chronic pain patients still have access.






Colorado legislature email addresses ending in @state.co.us are no longer active. Please replace @state.co.us with @coleg.gov for Colorado legislature email addresses. Details

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details